Featured Research

from universities, journals, and other organizations

Hysterectomy can elevate risk of stroke and coronary heart disease, study suggests

Date:
August 11, 2011
Source:
Deutsches Aerzteblatt International
Summary:
Hysterectomy elevates the risk of stroke and coronary heart disease in young women when combined with the removal of both ovaries in the same operation.

Hysterectomy elevates the risk of stroke and coronary heart disease in young women when combined with the removal of both ovaries in the same operation. This fact provides the background for the epidemiological report by Andreas Stang and colleagues on hysterectomy rates in Germany, which appears in the current issue of Deutsches Δrzteblatt International.

Removal of the uterus (hysterectomy) is among the commonest procedures in surgical gynecology. Stang et al. based their report on nationwide statistics relating to diagnosis-related groups (DRGs) in Germany for the years 2005 and 2006. They found that 4% of women under 50 who underwent hysterectomy for an indication other than cancer had a bilateral oophorectomy in the same operation, even though recent studies have shown that this is associated with an elevated risk of stroke and coronary heart disease.

The epidemiologists' assessment also revealed marked regional variation in hysterectomy rates across Germany. Fewer women underwent hysterectomy for benign indications in Hamburg, for example, than in Mecklenburg-West Pomerania over the same interval. Factors influencing the hysterectomy rate included not just the patient's concomitant illnesses, but also her social status and health insurance class and the sex of the gynecologist.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Andreas Stang, Ray M. Merrill, Oliver Kuss. Hysterectomy in Germany A DRG-Based Nationwide Analysis, 2005–2006. Deutsches Ärzteblatt International, 2011; 108(30): 508%u201314 DOI: 10.3238/arztebl.2011.0508

Cite This Page:

Deutsches Aerzteblatt International. "Hysterectomy can elevate risk of stroke and coronary heart disease, study suggests." ScienceDaily. ScienceDaily, 11 August 2011. <www.sciencedaily.com/releases/2011/08/110811094839.htm>.
Deutsches Aerzteblatt International. (2011, August 11). Hysterectomy can elevate risk of stroke and coronary heart disease, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/08/110811094839.htm
Deutsches Aerzteblatt International. "Hysterectomy can elevate risk of stroke and coronary heart disease, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/08/110811094839.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins